Cargando…

Erratum: Mapelli, S.N., et al. A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors). Cancers 2020, 12, 176

Detalles Bibliográficos
Autores principales:	Mapelli, Sarah N., Albino, Domenico, Mello-Grand, Maurizia, Shinde, Dheeraj, Scimeca, Manuel, Bonfiglio, Rita, Bonanno, Elena, Chiorino, Giovanna, Garcia-Escudero, Ramon, Catapano, Carlo V., Carbone, Giuseppina M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602137/ https://www.ncbi.nlm.nih.gov/pubmed/33066424 http://dx.doi.org/10.3390/cancers12102971

Ejemplares similares

A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)
por: Mapelli, Sarah N., et al.
Publicado: (2020)

Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients
por: Scimeca, Manuel, et al.
Publicado: (2018)

Erratum to “Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients”
por: Scimeca, Manuel, et al.
Publicado: (2019)

ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
por: Kunderfranco, Paolo, et al.
Publicado: (2010)

Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
por: Civenni, Gianluca, et al.
Publicado: (2019)

Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer
por: Lefort, Karine, et al.
Publicado: (2016)

EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
por: Zoma, Marita, et al.
Publicado: (2021)

[(99)Tc]Sestamibi bioaccumulation induces apoptosis in prostate cancer cells: an in vitro study
por: Urbano, Nicoletta, et al.
Publicado: (2022)

Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma
por: Ostano, Paola, et al.
Publicado: (2020)

Mitochondrial fission and stemness in prostate cancer
por: Civenni, Gianluca, et al.
Publicado: (2019)

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
por: Peraldo-Neia, Caterina, et al.
Publicado: (2011)

‘Stealth’ Prostate Tumors
por: Wagaskar, Vinayak G., et al.
Publicado: (2023)

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation
por: Bonfil, R. Daniel, et al.
Publicado: (2023)

The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis
por: Scimeca, Manuel, et al.
Publicado: (2022)

A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers
por: Pisignano, Giuseppina, et al.
Publicado: (2017)

(18)F–Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
por: Urbano, Nicoletta, et al.
Publicado: (2019)

Prostate stromal tumor with prostatic cysts after transurethral resection of the prostate: A case report
por: Zhao, Li-Wei, et al.
Publicado: (2021)

Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA
por: Mello-Grand, Maurizia, et al.
Publicado: (2021)

The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment
por: Albino, Domenico, et al.
Publicado: (2016)

Pseudosarcomatous Fibromyxoid Tumor of the Prostate
por: Atis, Gokhan, et al.
Publicado: (2011)

Extragastrointestinal stromal tumor of prostate
por: Almagharbi, Sarah A., et al.
Publicado: (2018)

Solitary Fibrous Tumor of the Prostate Which Was Initially Misdiagnosed as Prostate Cancer
por: Osamu, Soma, et al.
Publicado: (2017)

GRK2 Enforces Androgen Receptor-Dependence in the Prostate and Prostate Tumors
por: Adler, Adam J., et al.
Publicado: (2020)

Advances in landscape and related therapeutic targets of the prostate tumor microenvironment: Therapeutic targets of the prostate tumor microenvironment
por: Li, Duocai, et al.
Publicado: (2023)

Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival
por: Hägglöf, Christina, et al.
Publicado: (2010)

Circulating Tumor Cells in Prostate Cancer
por: Hu, Brian, et al.
Publicado: (2013)

Extra-Gastrointestinal Stromal Tumor of Prostate
por: Etit, Demet, et al.
Publicado: (2017)

The Tumor Immune Contexture of Prostate Cancer
por: Vitkin, Natasha, et al.
Publicado: (2019)

Rare and Challenging Tumor Entity: Phyllodes Tumor of the Prostate
por: Bannowsky, Andreas, et al.
Publicado: (2009)

Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer
por: Albino, Domenico, et al.
Publicado: (2021)

Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth
por: Halin Bergström, Sofia, et al.
Publicado: (2016)

Prostate zones and tumor morphological parameters on magnetic resonance imaging for predicting the tumor-stage diagnosis of prostate cancer
por: Xu, Shanshan, et al.
Publicado: (2023)

Prostate preserving resection of a rare giant peri-prostatic solitary fibrous tumor
por: Gilbert, Brent, et al.
Publicado: (2020)

Regulated Expression of CCL21 in the Prostate Tumor Microenvironment Inhibits Tumor Growth and Metastasis in an Orthotopic Model of Prostate Cancer
por: Yousefieh, Nazita, et al.
Publicado: (2009)

Proliferative Tumor Doubling Times of Prostatic Carcinoma
por: Werahera, Priya N., et al.
Publicado: (2011)

Promotion of tumor development in prostate cancer by progerin
por: Tang, Yong, et al.
Publicado: (2010)

A Large Cystic Phyllodes Tumor of the Prostate
por: Chung, Hyun Chul, et al.
Publicado: (2009)

Tumorigenic potential of circulating prostate tumor cells
por: Carvalho, Filipe LF., et al.
Publicado: (2013)

Modulation of cabozantinib efficacy by the prostate tumor microenvironment
por: Tripathi, Manisha, et al.
Publicado: (2017)

Applications of circulating tumor cells for prostate cancer
por: Cheng, Shirley, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r8tm66qtrsagit4cg9dkjckpq4